Uploaded September 2022 | Updated September 2026, 2 weeks ago
Shruti Gohil, MD, MPH, Assistant Professor in the Division of Infectious Diseases at the UCI School of Medicine and Associate Medical Director of Epidemiology & Infection Prevention. Dr. Gohil earned her Medical Doctorate from Tufts University School of Medicine, completed her residency in Internal Medicine at UC Davis, and held a Clinical and Research Fellowship in Infectious Diseases at the Albert Einstein School of Medicine in New York City. Dr. Gohil’s research focuses on infection prevention and antibiotic stewardship. She has led several large-scale epidemiologic studies evaluating patient risk for sepsis and hospital readmissions. She has created a novel scoring system to identify high risk patients to prevent central line associated bloodstream infections and is currently lead investigator of 4 large randomized controlled trials that develop a “precision medicine” approach to empiric antibiotic selection. In her current administrative role, she is leading UCI Health’s response to the COVID pandemic, including clinical and epidemiologic assessment of healthcare worker and patient management, COVID testing, exposure definition and response, contact tracing, infection prevention strategies to limit spread (e.g., PPE management, environmental handling and cleaning), and vaccination.
Shruti Gohil, MD, MPH, Assistant Professor in the Division of Infectious Diseases at the UCI School of Medicine and Associate Medical Director of Epidemiology & Infection Prevention. Dr. Gohil earned her Medical Doctorate from Tufts University School of Medicine, completed her residency in Internal Medicine at UC Davis, and held a Clinical and Research Fellowship in Infectious Diseases at the Albert Einstein School of Medicine in New York City. Dr. Gohil’s research focuses on infection prevention and antibiotic stewardship. She has led several large-scale epidemiologic studies evaluating patient risk for sepsis and hospital readmissions. She has created a novel scoring system to identify high risk patients to prevent central line associated bloodstream infections and is currently lead investigator of 4 large randomized controlled trials that develop a “precision medicine” approach to empiric antibiotic selection. In her current administrative role, she is leading UCI Health’s response to the COVID pandemic, including clinical and epidemiologic assessment of healthcare worker and patient management, COVID testing, exposure definition and response, contact tracing, infection prevention strategies to limit spread (e.g., PPE management, environmental handling and cleaning), and vaccination.
